Sitagliptin 100 mg tablets,Januvia (Sitagliptin 100 mg tablets)
Sponsors
Bio-innova and Synchron.Co.,Ltd
Conditions
Healthy subjects
Bioequivalence
Sitagliptin
Phase 1
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Sitagliptin 100 mg relative to Januvia (Sitagliptin 100 mg) in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20210830005
Start: 2021-12-23Target: 26Updated: 2026-08-03
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Sitagliptin 100 mg relative to Januvia (Sitagliptin 100 mg) in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20210927011
Start: 2021-11-24Target: 26Updated: 2026-08-03